NRX Pharmaceuticals share price logo

NRX Pharmaceuticals

NASDAQ: NRXP

$2.44

+0.29

(+13.72%)

as on

NRX Pharmaceuticals Stock Performance

as on November 18, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $2.11
    $2.47
    downward going graph

    13.52%

    Downside

    1.23%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.62
    $5.06
    downward going graph

    33.61%

    Downside

    107.17%

    Upside

    downward going graph

NRX Pharmaceuticals share price movements today

Previous Close
$2.15
Open
$2.15
Volume
1.5M
Market Cap
$95.6M
Day's Low - High
$2.11 - $2.47
52 Week Low - High
$1.62 - $5.06

NRX Pharmaceuticals Historical Returns

1 Month Return
-17.31 %
3 Month Return
-37.32 %
1 Year Return
+ 1.9 %
3 Year Return
-30.49 %
5 Year Return
-96.03 %

NRX Pharmaceuticals Stock Fundamentals & Key Indicators

Check NRX Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$95.6M

EPS (TTM)

-0.7429

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.95

Industry PE ratio

-2.76

PEG Ratio

-0.03

EBITDA

-21.9M

Revenue (TTM)

3.4M

Profit Margin

32.68%

Return On Equity TTM

168.68%

NRX Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of NRX Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$95.6M-96.03%-2.9532.68%0.00%
Neutral$100.6B0.07%-35.1828.00%0.00%
StrongBuy$47.6BNA67.0788.39%0.00%
StrongBuy$136.6B185.68%34.3985.57%0.00%
Buy$98.8B48.39%20.3585.77%0.39%

Stock Returns calculator for NRX Pharmaceuticals Stock including INR - Dollar returns

The NRX Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

NRX Pharmaceuticals investment value today

Current value as on today

₹1,21,933

Returns

₹21,933

(+21.93%)

Returns from NRX Pharmaceuticals Stock

₹15,640 (+15.64%)

Dollar Impact

₹6,294 (+6.29%)

Analyst Recommendation on NRX Pharmaceuticals Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for NRX Pharmaceuticals. Average target price of $48.33

NRX Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on NRX Pharmaceuticals.

What analysts predicted

94.95%UPSIDE

Target Price

$48.33

Current Price

$2.44

Analyzed by

2 Analysts

High

$45

Target

$48.33

Low

$12

NRX Pharmaceuticals target price $48.33, a slight upside of 94.95% compared to current price of $2.44. According to 2 analysts rating.

Indian Investors' Interest in NRX Pharmaceuticals Stock

Search interest for NRX Pharmaceuticals Stock has increased by 69% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:69% versus previous 30 day period

NRX Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
0
0
1
1
Gross Profit
0
0
0
0
-
-
0
0
0
0
Operating Income
-5
-7
-3
-3
-3
-3
-4
-4
-4
-6
EBITDA
-6
-7
-1
-9
-5
-17
-5
1
-1
-16
Interest Expense
0
0
-
-
-
-
-
0
0
0
Depreciation
0
0
0
0
0
-
0
0
0
0
Income Before Tax
-6
-7
-1
-9
-5
-17
-5
0
-1
-16
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-6
-7
-1
-9
-5
-17
-5
0
-1
-16
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
42.98%
48.32%
25.47%
23.43%

NRX Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Mar 2022
Dec 2022
Mar 2024
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
1
Gross Profit
-
-1
-
0
0
0
0
0
0
Operating Income
-
-1
0
-22
-95
-44
-27
-19
-16
EBITDA
0
0
0
-51
-93
-39
-30
-24
-27
Interest Expense
-
-
-
0
0
-
0
1
0
Depreciation
0
-
-
0
0
0
0
0
0
Income Before Tax
0
0
0
-51
-93
-39
-30
-25
-28
Income Tax Expense
-
0
0
-
-
-
-
-
-
Net Income
0
0
0
-51
-93
-39
-30
-25
-28
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
58.78%

NRX Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-6
-7
-1
-9
-5
-17
-5
0
-1
-16
Operating Cash Flow
-3
-3
-2
-2
-3
-4
-2
-3
-4
-8
Investing Cash Flow
-
-
-
-
-
-
-2
0
0
0
Financing Cash Flow
0
4
2
1
7
1
9
4
3
29
Change in Cash
-3
0
0
0
4
-2
4
0
-1
19

NRX Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Mar 2022
Dec 2022
Mar 2024
Dec 2024
Dec 2025
Net Income
0
0
0
-51
-93
-39
-30
-25
-28
Operating Cash Flow
0
0
0
-2
-37
-39
-21
-10
-14
Investing Cash Flow
-69
0
40
0
0
0
0
-
-2
Financing Cash Flow
69
0
-39
3
63
32
6
7
23
Change in Cash
0
0
0
0
25
-7
-15
-3
6

Global Institutional Holdings in NRX Pharmaceuticals

Check out the Institutions with significant holdings in NRX Pharmaceuticals.

Funds
Holdings
Bruce Winson
6.97%
Vanguard
4.01%
VANGUARD INDEX FUNDS
3.57%
Jonathan Javitt
3.48%
AdvisorShares
1.70%

NRX Pharmaceuticals News & Key Events

  • img

    Today's Timeline - 15 October

    Thu, 08:40 PM

    -

    NRx Pharmaceuticals receives FDA letter requesting minor label changes for its Preservative-Free Ketamine product ahead of GDUFA goal date.

Insights on NRX Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 181.6% return, outperforming this stock by 212.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 763.8% return, outperforming this stock by 769.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, NRXP stock has moved down by -11.9%

About NRX Pharmaceuticals

NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm focused on developing innovative therapies for disorders of the central nervous system and critical lung diseases. Its product portfolio features ZYESAMI, an experimental medication that has successfully completed Phase IIb/III clinical trials for treating respiratory failure associated with COVID-19. Additionally, the company is advancing NRX-100 and NRX-101, a pair of oral therapeutics designed to address bipolar depression, specifically in patients exhibiting acute or sub-acute suicidal thoughts and behaviors. Established in 2015, NRx Pharmaceuticals is headquartered in Wilmington, Delaware.
OrganisationNRX Pharmaceuticals
Headquarters1201 Orange Street, Wilmington, DE, 19801, US
IndustryBiotechnology
CEOJonathan C. Javitt

Key Management of NRX Pharmaceuticals

Name

Title

Dr. Jonathan C. Javitt M.D., M.P.H.

Co-Founder, Chairman & CEO

Mr. Michael S. Abrams M.B.A.

CFO & Treasurer

Prof. Joshua C. Brown M.D., Ph.D.

Chief Medical Innovation Officer

Mr. Glenn D. Tyson

Chief Commercial Officer

FAQs

What is NRX Pharmaceuticals share price today?

NRX Pharmaceuticals share price today is $2.44 as on at the close of the market. NRX Pharmaceuticals share today touched a day high of $2.47 and a low of $2.11.

What is the 52 week high and 52 week low for NRX Pharmaceuticals share?

NRX Pharmaceuticals share touched a 52 week high of $5.06 on and a 52 week low of $1.62 on . NRX Pharmaceuticals stock price today i.e. is closed at $2.44,which is 51.73% down from its 52 week high and 50.62% up from its 52 week low.

What is NRX Pharmaceuticals's market capitalisation today?

NRX Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in NRX Pharmaceuticals Stock (NRXP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for NRX Pharmaceuticals on INDmoney app. Click on Buy button.

What is the minimum amount required to buy NRX Pharmaceuticals Stock (NRXP) from India?

Indian investors can start investing in NRX Pharmaceuticals (NRXP) shares with as little as ₹93.459999084473 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹934.60 in NRX Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on NRX Pharmaceuticals share’s latest price of $2.44 as on November 18, 2026 at 2:29 am IST, you will get 4.0984 shares of NRX Pharmaceuticals. Learn more about fractional shares .

What are the returns that NRX Pharmaceuticals has given to Indian investors in the last 5 years?

NRX Pharmaceuticals stock has given -96.03% share price returns and 26.5% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?